Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08VKZ
|
|||
Former ID |
DIB001516
|
|||
Drug Name |
Edaglitazone
|
|||
Synonyms |
Edaglitazone sodium; BM-131258; BM-152054; R-483; Ro-205; BM-13.258; BM-15.2054; Ro-205-2349; Ro-2052349-602
Click to Show/Hide
|
|||
Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Terminated | [1] | |
Company |
Roche Holding AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H20N2O4S2
|
|||
Canonical SMILES |
CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=C4C=CSC4=C(C=C3)CC5C(=O)NC(=O)S5
|
|||
InChI |
1S/C24H20N2O4S2/c1-14-18(25-23(30-14)15-5-3-2-4-6-15)9-11-29-19-8-7-16(21-17(19)10-12-31-21)13-20-22(27)26-24(28)32-20/h2-8,10,12,20H,9,11,13H2,1H3,(H,26,27,28)
|
|||
InChIKey |
HAAXAFNSRADSMK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 213411-83-7
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats. Redox Rep. 2002;7(5):343-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.